Opens door to easy, early identification of individuals at risk for delirium complications
Regenstrief Institute and Indiana University School of Medicine researchers have identified blood-based biomarkers associated with both delirium duration and severity in critically ill patients. This finding opens the door to easy, early identification of individuals at risk for longer delirium duration and higher delirium severity and could potentially lead to new treatments of this brain failure for which drugs have been shown to be largely ineffective.
An estimated 7 million hospitalized Americans suffer from the acute confusion and disorientation, characteristics of delirium, including a majority of patients in medical or surgical intensive care units (ICUs). Individuals who experience delirium in the ICU are more likely to have more hospital-associated complications, longer stays and higher risk of readmission. They are more likely to experience cognitive impairment and also have a greater likelihood of dying for up to a year after their hospital stay than ICU patients who did not experience delirium.
“If you can tell which patients will have higher delirium severity and longer duration and therefore greater probability of death, there are important treatment implications,” said Regenstrief Institute research scientist and IU School of Medicine faculty member Babar Khan, M.D., who led the research and is the president of the American Delirium Society. “Analyzing biomarkers to stratify risk for delirium is a promising approach with the potential to be applied regularly in ICU patients in the near future.”
In a new observational study, Dr. Khan and colleagues report that biomarkers for astrocyte and glial activation as well as for inflammation were associated with increased delirium duration and severity and greater in-hospital mortality.
Biomarkers of the 321 study participants, all of whom experienced delirium in an ICU, were identified from samples obtained via simple blood draws. Delirium severity was determined using a tool developed by a team including Regenstrief, IU School of Medicine and Purdue College of Pharmacy scientists. The CAM-ICU-7, short for Confusion Assessment Method for the Intensive Care Unit 7 — is easy to administer, even to patients on mechanical ventilators. More than half of ICU patients in the U.S. receive mechanical ventilation.
Each day with delirium in the ICU is associated with a 10 percent increased likelihood of death, according to Dr. Khan, so diminishing its duration and ultimately preventing it is critical. Regenstrief, IU School of Medicine and research scientists from other institutions have conclusively shown in several large trials that antipsychotics, such as the widely used haloperidol, are not effective for the management of delirium duration or severity.
Regenstrief and IU School of Medicine researchers are actively exploring other approaches to delirium. Dr. Khan is co-principal investigator of an ongoing study that is the first to test whether listening to music, a non-pharmacological strategy that has been shown to decrease over-sedation, anxiety and stress in critically ill patients — all factors that predispose to ICU delirium – and lowers the likelihood of developing delirium. In a completed study, Regenstrief researchers determined that waking ICU patients and having them breathe on their own decreased acute brain failure.
The new study, “Biomarkers of Delirium Duration and Delirium Severity in the ICU” has been published online ahead of print in the journal Critical Care Medicine.
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
- How to live longer: Tea with a slice of lemon could reduce cancer risk and boost longevityon January 27, 2021 at 1:07 pm
Living longer may be achieved by adding a citrus fruit to your favourite hot beverage to not only fight off colds, potentially reduce cancer risks but also to boost your longevity.
- Heart attack: Sweating could indicate your risk of the deadly conditionon January 26, 2021 at 2:51 pm
HEART attacks are commonly attributed to unhealthy lifestyle decisions but there are other risk factors to watch out for. One warning sign is associated could lie in your sweat.
- Intensive care during COVID like a 'delirium factory', study findson January 25, 2021 at 9:06 pm
An international study of COVID-19 treatments has found patients admitted to intensive care early in the pandemic were treated by ‘outmoded’ sedation practices, leading to a doubling in their rates of ...
- Delirium Is Common In Covid-19 ICU Patients, But It Can Be Preventedon January 21, 2021 at 10:36 am
Brain dysfunction occurs at higher rates among Covid-19 patients compared to other ICU patients with similar lung problems, but it can be prevented.
- Cerebral Embolic Protection Use Low During TAVI, Not Tied to Stroke Riskon January 20, 2021 at 5:00 am
The retrospective German study showed, however, that use of Sentinel was associated with lower in-hospital mortality.
Go deeper with Google Headlines on:
Go deeper with Bing News on:
- Delirium Resolution in Hospitalized Older Patients With Canceron January 21, 2021 at 4:00 pm
A strength of the study was the daily assessment of delirium using an instrument that measures delirium severity and allows monitoring of changes in delirium over time.
- Nursing Care, Delirium, and Pain Management for the Hospitalized Older Adulton January 20, 2021 at 4:00 pm
For example, an older person with dementia is at a greatly increased risk for developing delirium. Other factors that may predispose these individuals include illness severity and environment with ...
- Steps outlined to reduce postop delirium in older adultson January 19, 2021 at 1:07 pm
Education and training programs should be developed by a multidisciplinary team to support identification of risk factors for delirium and other PNDs, discuss the risks, and manage patients with ...
- Can Covid-19 cause brain damage? Scientists to investigate whether coronavirus patients with neurological symptoms are affected long-termon January 19, 2021 at 3:46 am
Disease severity in the cohort varied from mild to critical and all the participants recovered, with symptoms ranging from delirium to a coma. Eight people in the study (42 per cent ...
- Can transgenic mice studies illuminate neurological complications associated with SARS-CoV-2 in humans?on January 18, 2021 at 6:34 am
The potentially deadly COVID-19 has not affected animals with corresponding severity. To understand the mechanism of severe disease, animal models have been used. This includes a mouse model that ...